The FTC is not anti-direct selling. It’s pro-truth in advertising.
The DSA misses the mark.
November 2016: This action was voluntarily dismissed pursuant to a settlement agreement reached between the parties, the terms of which have not been disclosed.
September 2016: The parties in a class-action lawsuit filed against Patent Health, L.L.C. in 2013 for allegedly deceptively marketing Trigosamine glucosamine supplements, reached a settlement agreement. The plaintiffs had alleged that the company deceptively claimed the supplements provide a variety of health benefits – including relieving joint pain, lubricating joints, and building cartilage – without adequate scientific evidence to support such claims. The terms of the settlement agreement have not been disclosed. (Vasic et al v. Patent Health, L.L.C. et al, Case No. 13-cv-849, S. D. CA.)
For more information about other class-action lawsuits regarding glucosamine supplements and TINA.org’s coverage of the products, click here.
The DSA misses the mark.
TINA.org reader takes issue with this product’s deceptive packaging.
Don’t let this company blindside you with its deceptive pricing.
Lawsuit pokes holes in company’s Swiss branding.
Why are these airport vendors slyly charging consumers for “employee benefits”?